CraniUS Therapeutics

CraniUS Therapeutics is pioneering the next frontier of neuro-implantable medicine. Its flagship platform—a fully implantable, refillable device—bypasses the blood-brain barrier to deliver therapeutic agents directly to targeted brain regions, dramatically reducing systemic side effects. Based in Baltimore and founded in 2021, CraniUS has been recognized by the Maryland Tech Council as the 2025 Emerging Life Sciences Company of the Year for its breakthrough approach to treating brain tumors, neurodegeneration, and other complex neurological conditions.

www.craniustherapeutics.com